معرفی
Ross McKinnon is a Matthew Flinders Distinguished Professor in the College of Medicine and Public Health at Flinders University. He previously served as Foundation Director of the Flinders Health and Medical Research Institute and Dean (Research). His career includes roles at the University of South Australia (UniSA), such as Inaugural Director of the Sansom Institute and Associate Head (Research) of the School of Pharmacy and Medical Sciences.
His research focuses on pharmacology, pharmaceutical biotechnology, and oncology, with contributions to cancer chemoprevention patents and anti-inflammatory compound discovery. He is a Fellow of the Australian Academy of Health and Medical Sciences and the International Pharmaceutical Federation (FIP). McKinnon currently chairs the FIP Board of Pharmaceutical Sciences and serves on the Therapeutic Innovation Australia board. He holds adjunct professorships at Monash University and co-chairs the IUPHAR World Congress of Pharmacology 2026 Program Committee.
His awards include the APSA Medallist, Flinders University Distinguished Alumni Award, and the Barrie L. Reed Distinguished Lecturer title. His work emphasizes translational research, particularly in drug development and improving healthcare outcomes through evidence-based practices.
- Education
- B Pharm (UniSA)
- B Sc (Hons) (Flinders)
- PhD (Flinders)
- Key Roles
- Chair, FIP Board of Pharmaceutical Sciences
- Board Member, Therapeutic Innovation Australia
- Adjunct Professor, Monash University
- Research Initiatives
- Precision approaches to anti-cancer medicines
- Glucuronidation and cancer research
- Traditional Indigenous medicine collaborations
- Grants & Funding
- NHMRC grants
- Cancer Council SA funding
